Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RTRX

Travere Therapeutics (RTRX) Stock Price, News & Analysis

Travere Therapeutics logo

About Travere Therapeutics Stock (NASDAQ:RTRX)

Advanced Chart

Key Stats

Today's Range
$14.69
$15.33
50-Day Range
$24.25
$28.18
52-Week Range
$8.98
$24.96
Volume
1.43 million shs
Average Volume
412,277 shs
Market Capitalization
$781.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RTRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Travere Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

RTRX Stock News Headlines

Travere Therapeutics Inc.
Trump’s New Order Could Boost Social Security Benefits by 400%
If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President Trump's Executive Order #14196 could not only save Social Security from collapse... ...but potentially increase benefits by up to 400%, according to legendary investor Louis Navellier.
See More Headlines

RTRX Stock Analysis - Frequently Asked Questions

Travere Therapeutics, Inc. (NASDAQ:RTRX) announced its quarterly earnings results on Thursday, November, 5th. The biopharmaceutical company reported ($0.44) earnings per share for the quarter, beating analysts' consensus estimates of ($0.59) by $0.15. Travere Therapeutics had a negative trailing twelve-month return on equity of 36.38% and a negative net margin of 49.13%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Travere Therapeutics investors own include CVS Health (CVS), Bristol Myers Squibb (BMY), Gilead Sciences (GILD), Novavax (NVAX), TG Therapeutics (TGTX), Dynavax Technologies (DVAX) and Intercept Pharmaceuticals (ICPT).

Company Calendar

Last Earnings
11/05/2020
Today
7/08/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:RTRX
CIK
1438533
Fax
N/A
Employees
221
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$146.43 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$175.34 million
Price / Cash Flow
N/A
Book Value
$5.15 per share
Price / Book
2.84

Miscellaneous

Free Float
N/A
Market Cap
$745.61 million
Optionable
Not Optionable
Beta
0.67
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:RTRX) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners